What is FluoroFinder?
FluoroFinder specializes in AI-driven solutions for fluorescence-based experiments, aiming to streamline the design process and minimize errors for researchers. The platform offers a comprehensive suite of tools, including flow cytometry panel design, antibody search functionalities, and an extensive fluorescent dye database. These capabilities cater to a wide array of life science applications such as flow cytometry, ELISA, and immunofluorescence. By providing access to over 3 million products from more than 78 suppliers, FluoroFinder empowers scientists to plan experiments with greater flexibility and optimization, establishing itself as a critical resource in the global research community.
How much funding has FluoroFinder raised?
FluoroFinder has raised a total of $4.4M across 2 funding rounds:
Debt
$1M
Private Equity
$3.4M
Debt (2014): $1M, investors not publicly disclosed
Private Equity (2016): $3.4M, investors not publicly disclosed
What's next for FluoroFinder?
The substantial enterprise-level funding secured by FluoroFinder positions the company for significant expansion and further development of its AI-powered experiment design platform. This strategic investment is likely to fuel advancements in its core offerings, potentially broadening its scope to encompass more complex experimental methodologies or enhancing its data analytics capabilities. FluoroFinder's focus on simplifying fluorescence experiments suggests a trajectory towards becoming an indispensable tool for academic institutions and biotechnology firms, driving innovation in drug discovery and diagnostics. Future growth may involve strategic partnerships and deeper integration into research workflows.
See full FluoroFinder company page
